Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-18-003201
Filing Date
2018-12-20
Accepted
2018-12-20 16:40:29
Documents
1
Period of Report
2018-12-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT zk1822401.html 4  
1 OWNERSHIP DOCUMENT zk1822401.xml 4 5750
  Complete submission text file 0001178913-18-003201.txt   7344
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 31905 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Issuer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 63 RABUTZKY STREET RAANANA L3 43220
Business Address
Aberman Zami (Reporting) CIK: 0001344740 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31392 | Film No.: 181246634